Phase 2 Esophagus Cancer Clinical Trials
7 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–7 of 7 trials
Recruiting
Phase 2
The Efficacy and Safety of Fosrolapitant and Palonosetron Hydrochloride for Injection in Preventing Nausea and Vomiting Caused by Multi-cycle Immunotherapy and Chemotherapy in Patients With Esophageal Cancer and Lung Cancer
Lung CancerEsophagus Cancer
Second Affiliated Hospital, School of Medicine, Zhejiang University120 enrolled1 locationNCT07617246
Recruiting
Phase 2
Predicting Esophageal Cancer Borders Using PET-Imaging
Esophagus Cancer, Stage IEsophagus Cancer, Stage II
University Hospital Heidelberg30 enrolled1 locationNCT06408116
Recruiting
Phase 2
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
Esophagus CancerStomach CancerStomach Cancer Stage IV
Massachusetts General Hospital40 enrolled2 locationsNCT07070466
Recruiting
Phase 1Phase 2
A Trial of the Combination of Afatinib and Palbociclib in Previously Treated Advanced Esophageal Squamous Cell Carcinoma
Esophagus Cancer
West China Hospital45 enrolled1 locationNCT06753747
Recruiting
Phase 2
Neoadjuvant Comprehensive Treatment for Unresectable Esophageal Cancer
Esophagus Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences90 enrolled1 locationNCT06430658
Recruiting
Phase 2
Induction Tislelizumab Combined With Chemotherapy Followed by Definitive Chemoradiotherapy in the Treatment of Locally Unresectable Esophageal Squamous Cell Carcinoma
Immunotherapy Esophagus Cancer
Fuzhou General Hospital93 enrolled1 locationNCT05515315
Recruiting
Phase 1Phase 2
Chemoradiotherapy in Elderly Patients With Oesophagus Cancer
Elderly PatientsOesophagus Cancer
Centre Hospitalier Universitaire de Besancon54 enrolled1 locationNCT02735057